Results for sars-cov-2

Add to feed Create your own feed

Latest

Woman looks for donor after COVID-19 damages her kidneys - Know how SARS-CoV-2 affects your renal health.

"Evidence is growing that self-attacking ‘autoantibodies’ could be the key to understanding some of the worst cases of SARS-CoV-2 infection"

"despite the many people who have already been infected with SARS-CoV-2 globally and are presumed to have accumulated some level of immunity, new variants such as 501Y.V2 pose a significant re-infection risk."

Loading
Loading

Most relevant

Today, FDA issued the first emergency use authorization (EUA) for a vaccine for the prevention of #COVID19  caused by SARS-CoV-2 in individuals 16 years of age and older. The emergency use authorization allows the vaccine to be distributed in the U.S.

tweet picture

BREAKING: Department of Health and Philippine Genome Center confirm the detection of B.1.1.7. SARS-CoV-2 variant (UK variant) in the country.

tweet picture

Today, FDA issued an emergency use authorization (EUA) for the second vaccine for the prevention of #COVID19  caused by SARS-CoV-2. The emergency use authorization allows the vaccine to be distributed in the U.S for use in individuals 18 years and older.

tweet picture

A 14-year-old has won $25,000 for a discovery that could provide a potential therapy to Covid-19. Anika Chebrolu's invention uses in-silico methodology to discover a lead molecule that can selectively bind to the spike protein of the SARS-CoV-2 virus.

A new variant of the pandemic SARS-CoV-2 coronavirus is spreading rapidly in Britain and prompting high levels of concern among its European neighbors. The strain is said to be up to 70% more transmissible than the previously dominant strain in the UK 1/5

In a first, Indian scientists have revealed a microscopy image of SARS-CoV-2 virus (COVID19). Scientists took the throat swab sample from first laboratory-confirmed COVID19 case in India, reported on Jan 30 in Kerala. The findings are published in the latest edition of the IJMR.

tweet picture

UPDATE: We are proud to announce, along with @BioNTech_Group , that our mRNA-based #vaccine  candidate has, at an interim analysis, demonstrated initial evidence of efficacy against #COVID19  in participants without prior evidence of SARS-CoV-2 infection.

More than 200 scientists have outlined evidence that they say shows the novel coronavirus can spread in tiny airborne particles, urging the @WHO  to update its guidance. Read our story on what we know so far about airborne transmission of SARS-CoV-2.

I wrote about the new coronavirus itself--where it came from, why it's behaving in the way it's behaving, how it infects and kills, and what the summer might bring. It's early days, of course, but this serves as a rough preliminary portrait of SARS-CoV-2.

Some not-horrible news on SARS-CoV-2 for once: It's mutating slowly considering how many people it has infected, which suggests a vaccine would be lasting, like vaccines for measles or chickenpox, rather than temporary like vaccines for flu. @JoelAchenbach 

Loading
Loading